The Two Substrate Reduction Therapies for Type 1 Gaucher Disease Are Not Equivalent. Comment on Hughes et al. Switching between Enzyme Replacement Therapies and Substrate Reduction Therapies in Patients with Gaucher Disease: Data from the Gaucher Outcome Survey (GOS). J. Clin. Med. 2022, 11, 5158

Pramod K. Mistry, Priya S. Kishnani, Manisha Balwani, Joel M. Charrow, Judy Hull, Neal J. Weinreb, Timothy M. Cox

Research output: Contribution to journalLetterpeer-review

3 Scopus citations
Original languageEnglish
Article number3269
JournalJournal of Clinical Medicine
Issue number9
StatePublished - May 2023

Cite this